nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—CYP2C9—Capecitabine—stomach cancer	0.0376	0.444	CbGbCtD
Agomelatine—CYP1A2—Fluorouracil—stomach cancer	0.0248	0.292	CbGbCtD
Agomelatine—CYP2C9—Fluorouracil—stomach cancer	0.0223	0.263	CbGbCtD
Agomelatine—Naproxen—AKR1C3—stomach cancer	0.00802	0.277	CrCbGaD
Agomelatine—Indomethacin—AKR1C3—stomach cancer	0.0065	0.224	CrCbGaD
Agomelatine—Indomethacin—CXCL8—stomach cancer	0.0039	0.135	CrCbGaD
Agomelatine—Nabumetone—PTGS2—stomach cancer	0.00304	0.105	CrCbGaD
Agomelatine—Hepatic failure—Capecitabine—stomach cancer	0.00273	0.00655	CcSEcCtD
Agomelatine—Infestation NOS—Fluorouracil—stomach cancer	0.00271	0.00649	CcSEcCtD
Agomelatine—Infestation—Fluorouracil—stomach cancer	0.00271	0.00649	CcSEcCtD
Agomelatine—Indomethacin—PPARG—stomach cancer	0.0027	0.0931	CrCbGaD
Agomelatine—Vomiting—Mitomycin—stomach cancer	0.00264	0.00633	CcSEcCtD
Agomelatine—Headache—Mitomycin—stomach cancer	0.0026	0.00623	CcSEcCtD
Agomelatine—Migraine—Docetaxel—stomach cancer	0.0025	0.00598	CcSEcCtD
Agomelatine—Connective tissue disorder—Irinotecan—stomach cancer	0.00249	0.00598	CcSEcCtD
Agomelatine—Nausea—Mitomycin—stomach cancer	0.00247	0.00591	CcSEcCtD
Agomelatine—Migraine—Capecitabine—stomach cancer	0.00242	0.00579	CcSEcCtD
Agomelatine—Face oedema—Capecitabine—stomach cancer	0.00237	0.00568	CcSEcCtD
Agomelatine—Phosphatase alkaline increased—Epirubicin—stomach cancer	0.00236	0.00565	CcSEcCtD
Agomelatine—Irritability—Capecitabine—stomach cancer	0.00234	0.00562	CcSEcCtD
Agomelatine—Abnormal dreams—Epirubicin—stomach cancer	0.00233	0.00558	CcSEcCtD
Agomelatine—Nasopharyngitis—Docetaxel—stomach cancer	0.00227	0.00544	CcSEcCtD
Agomelatine—Nasopharyngitis—Capecitabine—stomach cancer	0.00219	0.00526	CcSEcCtD
Agomelatine—Phosphatase alkaline increased—Doxorubicin—stomach cancer	0.00218	0.00523	CcSEcCtD
Agomelatine—Abnormal dreams—Doxorubicin—stomach cancer	0.00215	0.00516	CcSEcCtD
Agomelatine—Back pain—Irinotecan—stomach cancer	0.00214	0.00512	CcSEcCtD
Agomelatine—Influenza—Capecitabine—stomach cancer	0.00212	0.00509	CcSEcCtD
Agomelatine—Hepatic failure—Methotrexate—stomach cancer	0.00203	0.00487	CcSEcCtD
Agomelatine—Weight increased—Docetaxel—stomach cancer	0.00199	0.00478	CcSEcCtD
Agomelatine—Vision blurred—Fluorouracil—stomach cancer	0.00199	0.00478	CcSEcCtD
Agomelatine—Vertigo—Irinotecan—stomach cancer	0.00198	0.00476	CcSEcCtD
Agomelatine—Weight decreased—Docetaxel—stomach cancer	0.00198	0.00475	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Epirubicin—stomach cancer	0.00197	0.00471	CcSEcCtD
Agomelatine—Infestation NOS—Docetaxel—stomach cancer	0.00195	0.00468	CcSEcCtD
Agomelatine—Infestation—Docetaxel—stomach cancer	0.00195	0.00468	CcSEcCtD
Agomelatine—Weight increased—Capecitabine—stomach cancer	0.00193	0.00463	CcSEcCtD
Agomelatine—Weight decreased—Capecitabine—stomach cancer	0.00192	0.0046	CcSEcCtD
Agomelatine—Jaundice—Docetaxel—stomach cancer	0.0019	0.00457	CcSEcCtD
Agomelatine—Eczema—Epirubicin—stomach cancer	0.0019	0.00456	CcSEcCtD
Agomelatine—Hepatic failure—Epirubicin—stomach cancer	0.0019	0.00456	CcSEcCtD
Agomelatine—Infestation NOS—Capecitabine—stomach cancer	0.00189	0.00454	CcSEcCtD
Agomelatine—Infestation—Capecitabine—stomach cancer	0.00189	0.00454	CcSEcCtD
Agomelatine—Depression—Capecitabine—stomach cancer	0.00189	0.00452	CcSEcCtD
Agomelatine—Hepatobiliary disease—Docetaxel—stomach cancer	0.00185	0.00443	CcSEcCtD
Agomelatine—Jaundice—Capecitabine—stomach cancer	0.00184	0.00442	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Doxorubicin—stomach cancer	0.00182	0.00436	CcSEcCtD
Agomelatine—Infection—Irinotecan—stomach cancer	0.00179	0.00429	CcSEcCtD
Agomelatine—Hepatobiliary disease—Capecitabine—stomach cancer	0.00179	0.00429	CcSEcCtD
Agomelatine—Nervous system disorder—Irinotecan—stomach cancer	0.00177	0.00424	CcSEcCtD
Agomelatine—Hepatic failure—Doxorubicin—stomach cancer	0.00176	0.00422	CcSEcCtD
Agomelatine—Eczema—Doxorubicin—stomach cancer	0.00176	0.00422	CcSEcCtD
Agomelatine—Hepatitis—Docetaxel—stomach cancer	0.00175	0.0042	CcSEcCtD
Agomelatine—Irritability—Methotrexate—stomach cancer	0.00174	0.00418	CcSEcCtD
Agomelatine—Hyperhidrosis—Irinotecan—stomach cancer	0.00174	0.00418	CcSEcCtD
Agomelatine—Connective tissue disorder—Docetaxel—stomach cancer	0.00172	0.00413	CcSEcCtD
Agomelatine—Infection—Fluorouracil—stomach cancer	0.00171	0.00411	CcSEcCtD
Agomelatine—Hepatitis—Capecitabine—stomach cancer	0.0017	0.00407	CcSEcCtD
Agomelatine—Nervous system disorder—Fluorouracil—stomach cancer	0.00169	0.00406	CcSEcCtD
Agomelatine—Migraine—Epirubicin—stomach cancer	0.00168	0.00404	CcSEcCtD
Agomelatine—Connective tissue disorder—Capecitabine—stomach cancer	0.00167	0.004	CcSEcCtD
Agomelatine—Face oedema—Epirubicin—stomach cancer	0.00165	0.00396	CcSEcCtD
Agomelatine—Eye disorder—Docetaxel—stomach cancer	0.00164	0.00393	CcSEcCtD
Agomelatine—Insomnia—Irinotecan—stomach cancer	0.00163	0.00391	CcSEcCtD
Agomelatine—Paraesthesia—Irinotecan—stomach cancer	0.00162	0.00388	CcSEcCtD
Agomelatine—Somnolence—Irinotecan—stomach cancer	0.0016	0.00384	CcSEcCtD
Agomelatine—Eye disorder—Capecitabine—stomach cancer	0.00159	0.0038	CcSEcCtD
Agomelatine—Dyspepsia—Irinotecan—stomach cancer	0.00159	0.0038	CcSEcCtD
Agomelatine—Tinnitus—Capecitabine—stomach cancer	0.00158	0.0038	CcSEcCtD
Agomelatine—Insomnia—Fluorouracil—stomach cancer	0.00156	0.00374	CcSEcCtD
Agomelatine—Migraine—Doxorubicin—stomach cancer	0.00156	0.00373	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00156	0.00373	CcSEcCtD
Agomelatine—Fatigue—Irinotecan—stomach cancer	0.00155	0.00373	CcSEcCtD
Agomelatine—Paraesthesia—Fluorouracil—stomach cancer	0.00155	0.00372	CcSEcCtD
Agomelatine—Constipation—Irinotecan—stomach cancer	0.00154	0.0037	CcSEcCtD
Agomelatine—Mental disorder—Docetaxel—stomach cancer	0.00154	0.00368	CcSEcCtD
Agomelatine—Somnolence—Fluorouracil—stomach cancer	0.00153	0.00368	CcSEcCtD
Agomelatine—Nasopharyngitis—Epirubicin—stomach cancer	0.00153	0.00367	CcSEcCtD
Agomelatine—Face oedema—Doxorubicin—stomach cancer	0.00153	0.00366	CcSEcCtD
Agomelatine—Dyspepsia—Fluorouracil—stomach cancer	0.00152	0.00364	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00149	0.00357	CcSEcCtD
Agomelatine—Mental disorder—Capecitabine—stomach cancer	0.00149	0.00357	CcSEcCtD
Agomelatine—Influenza—Epirubicin—stomach cancer	0.00148	0.00354	CcSEcCtD
Agomelatine—Back pain—Docetaxel—stomach cancer	0.00148	0.00354	CcSEcCtD
Agomelatine—Gastrointestinal pain—Irinotecan—stomach cancer	0.00147	0.00353	CcSEcCtD
Agomelatine—Back pain—Capecitabine—stomach cancer	0.00143	0.00343	CcSEcCtD
Agomelatine—Abdominal pain—Irinotecan—stomach cancer	0.00142	0.00342	CcSEcCtD
Agomelatine—Nasopharyngitis—Doxorubicin—stomach cancer	0.00141	0.00339	CcSEcCtD
Agomelatine—Infestation NOS—Methotrexate—stomach cancer	0.00141	0.00338	CcSEcCtD
Agomelatine—Infestation—Methotrexate—stomach cancer	0.00141	0.00338	CcSEcCtD
Agomelatine—Naproxen—PTGS2—stomach cancer	0.00141	0.0485	CrCbGaD
Agomelatine—Depression—Methotrexate—stomach cancer	0.0014	0.00337	CcSEcCtD
Agomelatine—Vision blurred—Capecitabine—stomach cancer	0.00139	0.00334	CcSEcCtD
Agomelatine—Tremor—Capecitabine—stomach cancer	0.00138	0.00332	CcSEcCtD
Agomelatine—Urticaria—Fluorouracil—stomach cancer	0.00137	0.00329	CcSEcCtD
Agomelatine—Influenza—Doxorubicin—stomach cancer	0.00137	0.00328	CcSEcCtD
Agomelatine—Weight increased—Epirubicin—stomach cancer	0.00134	0.00322	CcSEcCtD
Agomelatine—Weight decreased—Epirubicin—stomach cancer	0.00134	0.00321	CcSEcCtD
Agomelatine—Hepatobiliary disease—Methotrexate—stomach cancer	0.00133	0.00319	CcSEcCtD
Agomelatine—Vertigo—Capecitabine—stomach cancer	0.00133	0.00318	CcSEcCtD
Agomelatine—Infestation NOS—Epirubicin—stomach cancer	0.00132	0.00316	CcSEcCtD
Agomelatine—Infestation—Epirubicin—stomach cancer	0.00132	0.00316	CcSEcCtD
Agomelatine—Asthenia—Irinotecan—stomach cancer	0.00129	0.0031	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00129	0.00309	CcSEcCtD
Agomelatine—Jaundice—Epirubicin—stomach cancer	0.00128	0.00308	CcSEcCtD
Agomelatine—Dry mouth—Docetaxel—stomach cancer	0.00127	0.00305	CcSEcCtD
Agomelatine—Hepatitis—Methotrexate—stomach cancer	0.00126	0.00303	CcSEcCtD
Agomelatine—Anxiety—Capecitabine—stomach cancer	0.00125	0.00301	CcSEcCtD
Agomelatine—Naproxen—ALB—stomach cancer	0.00125	0.0432	CrCbGaD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00125	0.003	CcSEcCtD
Agomelatine—Hepatobiliary disease—Epirubicin—stomach cancer	0.00125	0.00299	CcSEcCtD
Agomelatine—Weight increased—Doxorubicin—stomach cancer	0.00124	0.00298	CcSEcCtD
Agomelatine—Infection—Docetaxel—stomach cancer	0.00124	0.00297	CcSEcCtD
Agomelatine—Weight decreased—Doxorubicin—stomach cancer	0.00124	0.00297	CcSEcCtD
Agomelatine—Diarrhoea—Irinotecan—stomach cancer	0.00123	0.00296	CcSEcCtD
Agomelatine—Dry mouth—Capecitabine—stomach cancer	0.00123	0.00295	CcSEcCtD
Agomelatine—Nervous system disorder—Docetaxel—stomach cancer	0.00122	0.00293	CcSEcCtD
Agomelatine—Pruritus—Fluorouracil—stomach cancer	0.00122	0.00293	CcSEcCtD
Agomelatine—Infestation NOS—Doxorubicin—stomach cancer	0.00122	0.00292	CcSEcCtD
Agomelatine—Infestation—Doxorubicin—stomach cancer	0.00122	0.00292	CcSEcCtD
Agomelatine—Skin disorder—Docetaxel—stomach cancer	0.00121	0.0029	CcSEcCtD
Agomelatine—Infection—Capecitabine—stomach cancer	0.0012	0.00287	CcSEcCtD
Agomelatine—Dizziness—Irinotecan—stomach cancer	0.00119	0.00286	CcSEcCtD
Agomelatine—Jaundice—Doxorubicin—stomach cancer	0.00119	0.00285	CcSEcCtD
Agomelatine—Nervous system disorder—Capecitabine—stomach cancer	0.00118	0.00284	CcSEcCtD
Agomelatine—Hepatitis—Epirubicin—stomach cancer	0.00118	0.00284	CcSEcCtD
Agomelatine—Eye disorder—Methotrexate—stomach cancer	0.00118	0.00283	CcSEcCtD
Agomelatine—Diarrhoea—Fluorouracil—stomach cancer	0.00118	0.00283	CcSEcCtD
Agomelatine—Tinnitus—Methotrexate—stomach cancer	0.00118	0.00283	CcSEcCtD
Agomelatine—Skin disorder—Capecitabine—stomach cancer	0.00117	0.00281	CcSEcCtD
Agomelatine—Hyperhidrosis—Capecitabine—stomach cancer	0.00117	0.0028	CcSEcCtD
Agomelatine—Connective tissue disorder—Epirubicin—stomach cancer	0.00116	0.00279	CcSEcCtD
Agomelatine—Hepatobiliary disease—Doxorubicin—stomach cancer	0.00115	0.00276	CcSEcCtD
Agomelatine—Vomiting—Irinotecan—stomach cancer	0.00115	0.00275	CcSEcCtD
Agomelatine—Dizziness—Fluorouracil—stomach cancer	0.00114	0.00274	CcSEcCtD
Agomelatine—Indomethacin—PTGS2—stomach cancer	0.00114	0.0393	CrCbGaD
Agomelatine—Headache—Irinotecan—stomach cancer	0.00113	0.00271	CcSEcCtD
Agomelatine—Insomnia—Docetaxel—stomach cancer	0.00113	0.0027	CcSEcCtD
Agomelatine—Paraesthesia—Docetaxel—stomach cancer	0.00112	0.00268	CcSEcCtD
Agomelatine—Somnolence—Docetaxel—stomach cancer	0.00111	0.00266	CcSEcCtD
Agomelatine—Mental disorder—Methotrexate—stomach cancer	0.00111	0.00266	CcSEcCtD
Agomelatine—Eye disorder—Epirubicin—stomach cancer	0.00111	0.00265	CcSEcCtD
Agomelatine—Tinnitus—Epirubicin—stomach cancer	0.0011	0.00264	CcSEcCtD
Agomelatine—Vomiting—Fluorouracil—stomach cancer	0.0011	0.00263	CcSEcCtD
Agomelatine—Dyspepsia—Docetaxel—stomach cancer	0.0011	0.00263	CcSEcCtD
Agomelatine—Hepatitis—Doxorubicin—stomach cancer	0.00109	0.00262	CcSEcCtD
Agomelatine—Insomnia—Capecitabine—stomach cancer	0.00109	0.00262	CcSEcCtD
Agomelatine—Paraesthesia—Capecitabine—stomach cancer	0.00108	0.0026	CcSEcCtD
Agomelatine—Headache—Fluorouracil—stomach cancer	0.00108	0.00259	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00108	0.00258	CcSEcCtD
Agomelatine—Connective tissue disorder—Doxorubicin—stomach cancer	0.00108	0.00258	CcSEcCtD
Agomelatine—Fatigue—Docetaxel—stomach cancer	0.00107	0.00258	CcSEcCtD
Agomelatine—Nausea—Irinotecan—stomach cancer	0.00107	0.00257	CcSEcCtD
Agomelatine—Constipation—Docetaxel—stomach cancer	0.00107	0.00255	CcSEcCtD
Agomelatine—Back pain—Methotrexate—stomach cancer	0.00106	0.00255	CcSEcCtD
Agomelatine—Dyspepsia—Capecitabine—stomach cancer	0.00106	0.00255	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00104	0.0025	CcSEcCtD
Agomelatine—Fatigue—Capecitabine—stomach cancer	0.00104	0.00249	CcSEcCtD
Agomelatine—Vision blurred—Methotrexate—stomach cancer	0.00104	0.00249	CcSEcCtD
Agomelatine—Mental disorder—Epirubicin—stomach cancer	0.00104	0.00248	CcSEcCtD
Agomelatine—Constipation—Capecitabine—stomach cancer	0.00103	0.00247	CcSEcCtD
Agomelatine—Nausea—Fluorouracil—stomach cancer	0.00103	0.00246	CcSEcCtD
Agomelatine—Eye disorder—Doxorubicin—stomach cancer	0.00102	0.00245	CcSEcCtD
Agomelatine—Tinnitus—Doxorubicin—stomach cancer	0.00102	0.00245	CcSEcCtD
Agomelatine—Gastrointestinal pain—Docetaxel—stomach cancer	0.00102	0.00244	CcSEcCtD
Agomelatine—Indomethacin—ALB—stomach cancer	0.00101	0.035	CrCbGaD
Agomelatine—Back pain—Epirubicin—stomach cancer	0.000996	0.00239	CcSEcCtD
Agomelatine—Vertigo—Methotrexate—stomach cancer	0.000989	0.00237	CcSEcCtD
Agomelatine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000986	0.00237	CcSEcCtD
Agomelatine—Abdominal pain—Docetaxel—stomach cancer	0.000985	0.00236	CcSEcCtD
Agomelatine—Vision blurred—Epirubicin—stomach cancer	0.00097	0.00233	CcSEcCtD
Agomelatine—Mental disorder—Doxorubicin—stomach cancer	0.000959	0.0023	CcSEcCtD
Agomelatine—Urticaria—Capecitabine—stomach cancer	0.000958	0.0023	CcSEcCtD
Agomelatine—Abdominal pain—Capecitabine—stomach cancer	0.000954	0.00229	CcSEcCtD
Agomelatine—Agitation—Epirubicin—stomach cancer	0.000946	0.00227	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00093	0.00223	CcSEcCtD
Agomelatine—Vertigo—Epirubicin—stomach cancer	0.000925	0.00222	CcSEcCtD
Agomelatine—Back pain—Doxorubicin—stomach cancer	0.000922	0.00221	CcSEcCtD
Agomelatine—Vision blurred—Doxorubicin—stomach cancer	0.000898	0.00215	CcSEcCtD
Agomelatine—Asthenia—Docetaxel—stomach cancer	0.000894	0.00214	CcSEcCtD
Agomelatine—Infection—Methotrexate—stomach cancer	0.000892	0.00214	CcSEcCtD
Agomelatine—Pruritus—Docetaxel—stomach cancer	0.000882	0.00211	CcSEcCtD
Agomelatine—Nervous system disorder—Methotrexate—stomach cancer	0.000881	0.00211	CcSEcCtD
Agomelatine—Agitation—Doxorubicin—stomach cancer	0.000876	0.0021	CcSEcCtD
Agomelatine—Anxiety—Epirubicin—stomach cancer	0.000874	0.00209	CcSEcCtD
Agomelatine—Skin disorder—Methotrexate—stomach cancer	0.000872	0.00209	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000871	0.00209	CcSEcCtD
Agomelatine—Hyperhidrosis—Methotrexate—stomach cancer	0.000868	0.00208	CcSEcCtD
Agomelatine—Asthenia—Capecitabine—stomach cancer	0.000866	0.00208	CcSEcCtD
Agomelatine—Dry mouth—Epirubicin—stomach cancer	0.000857	0.00206	CcSEcCtD
Agomelatine—Vertigo—Doxorubicin—stomach cancer	0.000856	0.00205	CcSEcCtD
Agomelatine—Pruritus—Capecitabine—stomach cancer	0.000853	0.00205	CcSEcCtD
Agomelatine—Diarrhoea—Docetaxel—stomach cancer	0.000852	0.00204	CcSEcCtD
Agomelatine—Infection—Epirubicin—stomach cancer	0.000835	0.002	CcSEcCtD
Agomelatine—Diarrhoea—Capecitabine—stomach cancer	0.000825	0.00198	CcSEcCtD
Agomelatine—Nervous system disorder—Epirubicin—stomach cancer	0.000824	0.00198	CcSEcCtD
Agomelatine—Dizziness—Docetaxel—stomach cancer	0.000824	0.00198	CcSEcCtD
Agomelatine—Skin disorder—Epirubicin—stomach cancer	0.000816	0.00196	CcSEcCtD
Agomelatine—Hyperhidrosis—Epirubicin—stomach cancer	0.000812	0.00195	CcSEcCtD
Agomelatine—Insomnia—Methotrexate—stomach cancer	0.000812	0.00195	CcSEcCtD
Agomelatine—Anxiety—Doxorubicin—stomach cancer	0.000808	0.00194	CcSEcCtD
Agomelatine—Paraesthesia—Methotrexate—stomach cancer	0.000806	0.00193	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000806	0.00193	CcSEcCtD
Agomelatine—Somnolence—Methotrexate—stomach cancer	0.000798	0.00191	CcSEcCtD
Agomelatine—Dizziness—Capecitabine—stomach cancer	0.000798	0.00191	CcSEcCtD
Agomelatine—Dry mouth—Doxorubicin—stomach cancer	0.000793	0.0019	CcSEcCtD
Agomelatine—Vomiting—Docetaxel—stomach cancer	0.000792	0.0019	CcSEcCtD
Agomelatine—Dyspepsia—Methotrexate—stomach cancer	0.00079	0.0019	CcSEcCtD
Agomelatine—Headache—Docetaxel—stomach cancer	0.000781	0.00187	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000775	0.00186	CcSEcCtD
Agomelatine—Fatigue—Methotrexate—stomach cancer	0.000774	0.00186	CcSEcCtD
Agomelatine—Infection—Doxorubicin—stomach cancer	0.000773	0.00185	CcSEcCtD
Agomelatine—Vomiting—Capecitabine—stomach cancer	0.000767	0.00184	CcSEcCtD
Agomelatine—Nervous system disorder—Doxorubicin—stomach cancer	0.000763	0.00183	CcSEcCtD
Agomelatine—Insomnia—Epirubicin—stomach cancer	0.00076	0.00182	CcSEcCtD
Agomelatine—Headache—Capecitabine—stomach cancer	0.000756	0.00181	CcSEcCtD
Agomelatine—Skin disorder—Doxorubicin—stomach cancer	0.000755	0.00181	CcSEcCtD
Agomelatine—Paraesthesia—Epirubicin—stomach cancer	0.000755	0.00181	CcSEcCtD
Agomelatine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000752	0.0018	CcSEcCtD
Agomelatine—Somnolence—Epirubicin—stomach cancer	0.000747	0.00179	CcSEcCtD
Agomelatine—Nausea—Docetaxel—stomach cancer	0.00074	0.00177	CcSEcCtD
Agomelatine—Dyspepsia—Epirubicin—stomach cancer	0.00074	0.00177	CcSEcCtD
Agomelatine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000734	0.00176	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000726	0.00174	CcSEcCtD
Agomelatine—Fatigue—Epirubicin—stomach cancer	0.000725	0.00174	CcSEcCtD
Agomelatine—Constipation—Epirubicin—stomach cancer	0.000719	0.00172	CcSEcCtD
Agomelatine—Nausea—Capecitabine—stomach cancer	0.000717	0.00172	CcSEcCtD
Agomelatine—Urticaria—Methotrexate—stomach cancer	0.000713	0.00171	CcSEcCtD
Agomelatine—Abdominal pain—Methotrexate—stomach cancer	0.00071	0.0017	CcSEcCtD
Agomelatine—Insomnia—Doxorubicin—stomach cancer	0.000703	0.00169	CcSEcCtD
Agomelatine—Paraesthesia—Doxorubicin—stomach cancer	0.000698	0.00167	CcSEcCtD
Agomelatine—Somnolence—Doxorubicin—stomach cancer	0.000691	0.00166	CcSEcCtD
Agomelatine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000687	0.00165	CcSEcCtD
Agomelatine—Dyspepsia—Doxorubicin—stomach cancer	0.000684	0.00164	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000671	0.00161	CcSEcCtD
Agomelatine—Fatigue—Doxorubicin—stomach cancer	0.00067	0.00161	CcSEcCtD
Agomelatine—Urticaria—Epirubicin—stomach cancer	0.000668	0.0016	CcSEcCtD
Agomelatine—Constipation—Doxorubicin—stomach cancer	0.000665	0.00159	CcSEcCtD
Agomelatine—Abdominal pain—Epirubicin—stomach cancer	0.000664	0.00159	CcSEcCtD
Agomelatine—Asthenia—Methotrexate—stomach cancer	0.000644	0.00154	CcSEcCtD
Agomelatine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000636	0.00152	CcSEcCtD
Agomelatine—Pruritus—Methotrexate—stomach cancer	0.000635	0.00152	CcSEcCtD
Agomelatine—Urticaria—Doxorubicin—stomach cancer	0.000618	0.00148	CcSEcCtD
Agomelatine—Abdominal pain—Doxorubicin—stomach cancer	0.000615	0.00147	CcSEcCtD
Agomelatine—Diarrhoea—Methotrexate—stomach cancer	0.000614	0.00147	CcSEcCtD
Agomelatine—Asthenia—Epirubicin—stomach cancer	0.000603	0.00145	CcSEcCtD
Agomelatine—Pruritus—Epirubicin—stomach cancer	0.000595	0.00143	CcSEcCtD
Agomelatine—Dizziness—Methotrexate—stomach cancer	0.000594	0.00142	CcSEcCtD
Agomelatine—Diarrhoea—Epirubicin—stomach cancer	0.000575	0.00138	CcSEcCtD
Agomelatine—Vomiting—Methotrexate—stomach cancer	0.000571	0.00137	CcSEcCtD
Agomelatine—Headache—Methotrexate—stomach cancer	0.000563	0.00135	CcSEcCtD
Agomelatine—Asthenia—Doxorubicin—stomach cancer	0.000558	0.00134	CcSEcCtD
Agomelatine—Dizziness—Epirubicin—stomach cancer	0.000556	0.00133	CcSEcCtD
Agomelatine—Pruritus—Doxorubicin—stomach cancer	0.00055	0.00132	CcSEcCtD
Agomelatine—Vomiting—Epirubicin—stomach cancer	0.000534	0.00128	CcSEcCtD
Agomelatine—Nausea—Methotrexate—stomach cancer	0.000533	0.00128	CcSEcCtD
Agomelatine—Diarrhoea—Doxorubicin—stomach cancer	0.000532	0.00128	CcSEcCtD
Agomelatine—Headache—Epirubicin—stomach cancer	0.000526	0.00126	CcSEcCtD
Agomelatine—Dizziness—Doxorubicin—stomach cancer	0.000514	0.00123	CcSEcCtD
Agomelatine—Nausea—Epirubicin—stomach cancer	0.000499	0.0012	CcSEcCtD
Agomelatine—Vomiting—Doxorubicin—stomach cancer	0.000494	0.00119	CcSEcCtD
Agomelatine—Headache—Doxorubicin—stomach cancer	0.000487	0.00117	CcSEcCtD
Agomelatine—Nausea—Doxorubicin—stomach cancer	0.000462	0.00111	CcSEcCtD
Agomelatine—HTR2C—Signaling Pathways—FGG—stomach cancer	0.000128	0.000273	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—BLVRB—stomach cancer	0.000127	0.000272	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PGLS—stomach cancer	0.000127	0.000272	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HSPB1—stomach cancer	0.000127	0.000271	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AGTR2—stomach cancer	0.000127	0.000271	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—FBP1—stomach cancer	0.000127	0.00027	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NDUFA2—stomach cancer	0.000127	0.00027	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CA1—stomach cancer	0.000127	0.00027	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CKB—stomach cancer	0.000127	0.00027	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—ADRB2—stomach cancer	0.000127	0.00027	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—BMP2—stomach cancer	0.000126	0.000268	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—F2R—stomach cancer	0.000126	0.000268	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MMP9—stomach cancer	0.000126	0.000268	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MMP9—stomach cancer	0.000126	0.000268	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CDKN1A—stomach cancer	0.000125	0.000267	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CDKN1A—stomach cancer	0.000125	0.000267	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PPP2R1A—stomach cancer	0.000124	0.000265	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000124	0.000264	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKR1C3—stomach cancer	0.000124	0.000264	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PRKAA1—stomach cancer	0.000124	0.000263	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR1A—stomach cancer	0.000122	0.000261	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MAPK8—stomach cancer	0.000122	0.00026	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MAPK8—stomach cancer	0.000122	0.00026	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPAP2A—stomach cancer	0.000122	0.000259	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RBP4—stomach cancer	0.000119	0.000254	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CXCL8—stomach cancer	0.000119	0.000254	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PLIN2—stomach cancer	0.000119	0.000254	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000119	0.000253	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PRKCB—stomach cancer	0.000119	0.000253	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ANXA1—stomach cancer	0.000118	0.000252	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.000117	0.000249	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CA2—stomach cancer	0.000116	0.000247	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADRB1—stomach cancer	0.000115	0.000244	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PGAM1—stomach cancer	0.000113	0.000241	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NT5E—stomach cancer	0.000113	0.000241	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—VEGFA—stomach cancer	0.000113	0.00024	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—VEGFA—stomach cancer	0.000113	0.00024	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—STAT3—stomach cancer	0.000112	0.000238	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—STAT3—stomach cancer	0.000112	0.000238	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RPS6—stomach cancer	0.000109	0.000233	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CKB—stomach cancer	0.000108	0.000231	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CA1—stomach cancer	0.000108	0.000231	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NDUFA2—stomach cancer	0.000108	0.000231	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—FBP1—stomach cancer	0.000108	0.000231	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PLCE1—stomach cancer	0.000108	0.00023	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALDH7A1—stomach cancer	0.000108	0.00023	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PRKCB—stomach cancer	0.000108	0.000229	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6ST—stomach cancer	0.000107	0.000228	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MAPK3—stomach cancer	0.000107	0.000227	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MAPK3—stomach cancer	0.000107	0.000227	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MYC—stomach cancer	0.000104	0.000221	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MYC—stomach cancer	0.000104	0.000221	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—UMPS—stomach cancer	0.000103	0.00022	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AGTR2—stomach cancer	0.000103	0.000219	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HSPB1—stomach cancer	0.000103	0.000219	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PLIN2—stomach cancer	0.000102	0.000217	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MAPK1—stomach cancer	0.000101	0.000216	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MAPK1—stomach cancer	0.000101	0.000216	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—EGFR—stomach cancer	0.000101	0.000216	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—EGFR—stomach cancer	0.000101	0.000216	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—BMP2—stomach cancer	0.000101	0.000216	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—F2R—stomach cancer	0.000101	0.000216	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HBEGF—stomach cancer	0.000101	0.000214	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKR1C3—stomach cancer	9.98e-05	0.000213	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CA2—stomach cancer	9.91e-05	0.000211	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR1A—stomach cancer	9.88e-05	0.00021	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NT5E—stomach cancer	9.66e-05	0.000206	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PGAM1—stomach cancer	9.66e-05	0.000206	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PDHA1—stomach cancer	9.61e-05	0.000205	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ECHS1—stomach cancer	9.61e-05	0.000205	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—KRAS—stomach cancer	9.58e-05	0.000204	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—KRAS—stomach cancer	9.58e-05	0.000204	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6R—stomach cancer	9.57e-05	0.000204	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PRKCB—stomach cancer	9.56e-05	0.000204	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ANXA1—stomach cancer	9.54e-05	0.000203	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—RHOA—stomach cancer	9.52e-05	0.000203	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADRB2—stomach cancer	9.28e-05	0.000198	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADRB1—stomach cancer	9.24e-05	0.000197	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALDH7A1—stomach cancer	9.21e-05	0.000196	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PLCE1—stomach cancer	9.21e-05	0.000196	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PPP2R1A—stomach cancer	9.09e-05	0.000194	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TYMP—stomach cancer	9.04e-05	0.000193	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—FADS1—stomach cancer	9.04e-05	0.000193	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—UMPS—stomach cancer	8.83e-05	0.000188	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RPS6—stomach cancer	8.83e-05	0.000188	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—PIK3CA—stomach cancer	8.81e-05	0.000188	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PIK3CA—stomach cancer	8.81e-05	0.000188	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PRKCB—stomach cancer	8.68e-05	0.000185	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6ST—stomach cancer	8.65e-05	0.000184	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—RHOA—stomach cancer	8.64e-05	0.000184	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TP53—stomach cancer	8.52e-05	0.000182	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TP53—stomach cancer	8.52e-05	0.000182	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SREBF2—stomach cancer	8.46e-05	0.00018	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SMAD4—stomach cancer	8.44e-05	0.00018	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—RORA—stomach cancer	8.36e-05	0.000178	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCL8—stomach cancer	8.35e-05	0.000178	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PDHA1—stomach cancer	8.21e-05	0.000175	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ECHS1—stomach cancer	8.21e-05	0.000175	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HRAS—stomach cancer	8.15e-05	0.000174	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HRAS—stomach cancer	8.15e-05	0.000174	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HBEGF—stomach cancer	8.11e-05	0.000173	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FYN—stomach cancer	8.02e-05	0.000171	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALDOB—stomach cancer	7.83e-05	0.000167	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL6—stomach cancer	7.8e-05	0.000166	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL6—stomach cancer	7.8e-05	0.000166	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TYMP—stomach cancer	7.72e-05	0.000165	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—FADS1—stomach cancer	7.72e-05	0.000165	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6R—stomach cancer	7.72e-05	0.000164	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—RHOA—stomach cancer	7.68e-05	0.000164	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCL8—stomach cancer	7.59e-05	0.000162	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FGFR2—stomach cancer	7.52e-05	0.00016	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADRB2—stomach cancer	7.49e-05	0.000159	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	7.39e-05	0.000157	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	7.37e-05	0.000157	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PPP2R1A—stomach cancer	7.34e-05	0.000156	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALOX5—stomach cancer	7.28e-05	0.000155	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SREBF2—stomach cancer	7.23e-05	0.000154	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—DPYD—stomach cancer	7.17e-05	0.000153	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—RORA—stomach cancer	7.14e-05	0.000152	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—RHOA—stomach cancer	6.97e-05	0.000149	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IRS2—stomach cancer	6.89e-05	0.000147	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SMAD4—stomach cancer	6.81e-05	0.000145	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCL8—stomach cancer	6.74e-05	0.000144	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALDOB—stomach cancer	6.69e-05	0.000143	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CAV1—stomach cancer	6.68e-05	0.000142	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOA1—stomach cancer	6.67e-05	0.000142	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.49e-05	0.000138	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FYN—stomach cancer	6.47e-05	0.000138	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PRKCB—stomach cancer	6.36e-05	0.000135	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTT1—stomach cancer	6.34e-05	0.000135	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6ST—stomach cancer	6.33e-05	0.000135	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.31e-05	0.000135	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.3e-05	0.000134	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP2A6—stomach cancer	6.26e-05	0.000133	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALOX5—stomach cancer	6.22e-05	0.000133	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—DPYD—stomach cancer	6.12e-05	0.00013	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCL8—stomach cancer	6.12e-05	0.00013	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AKR1C3—stomach cancer	6.09e-05	0.00013	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APC—stomach cancer	6.09e-05	0.00013	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FGFR2—stomach cancer	6.07e-05	0.000129	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ENO1—stomach cancer	5.94e-05	0.000127	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.84e-05	0.000124	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—MAPK3—stomach cancer	5.83e-05	0.000124	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6R—stomach cancer	5.65e-05	0.00012	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IRS2—stomach cancer	5.56e-05	0.000118	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.55e-05	0.000118	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—MAPK1—stomach cancer	5.55e-05	0.000118	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—EGFR—stomach cancer	5.54e-05	0.000118	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTT1—stomach cancer	5.41e-05	0.000115	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CAV1—stomach cancer	5.39e-05	0.000115	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOA1—stomach cancer	5.38e-05	0.000115	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP2A6—stomach cancer	5.35e-05	0.000114	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PIK3CA—stomach cancer	5.3e-05	0.000113	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SERPINE1—stomach cancer	5.29e-05	0.000113	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CD44—stomach cancer	5.27e-05	0.000112	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—KRAS—stomach cancer	5.24e-05	0.000112	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AKR1C3—stomach cancer	5.21e-05	0.000111	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PRKCB—stomach cancer	5.13e-05	0.000109	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6ST—stomach cancer	5.11e-05	0.000109	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.11e-05	0.000109	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RHOA—stomach cancer	5.1e-05	0.000109	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ENO1—stomach cancer	5.07e-05	0.000108	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOS3—stomach cancer	5.05e-05	0.000108	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.99e-05	0.000106	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APC—stomach cancer	4.91e-05	0.000105	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PIK3CA—stomach cancer	4.81e-05	0.000103	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ERBB2—stomach cancer	4.73e-05	0.000101	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—MAPK3—stomach cancer	4.7e-05	0.0001	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6R—stomach cancer	4.56e-05	9.71e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CD44—stomach cancer	4.5e-05	9.59e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCL8—stomach cancer	4.48e-05	9.55e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPP2R1A—stomach cancer	4.48e-05	9.54e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—MAPK1—stomach cancer	4.47e-05	9.53e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—EGFR—stomach cancer	4.47e-05	9.53e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HRAS—stomach cancer	4.45e-05	9.49e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTP1—stomach cancer	4.39e-05	9.36e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CDKN1B—stomach cancer	4.38e-05	9.32e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.37e-05	9.3e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HMOX1—stomach cancer	4.33e-05	9.23e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PIK3CA—stomach cancer	4.28e-05	9.11e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SERPINE1—stomach cancer	4.27e-05	9.1e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6—stomach cancer	4.26e-05	9.08e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—KRAS—stomach cancer	4.23e-05	9e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCND1—stomach cancer	4.17e-05	8.9e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—JUN—stomach cancer	4.17e-05	8.88e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RHOA—stomach cancer	4.12e-05	8.77e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TYMS—stomach cancer	4.08e-05	8.7e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOS3—stomach cancer	4.08e-05	8.68e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MMP9—stomach cancer	4.05e-05	8.64e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CDKN1A—stomach cancer	4.04e-05	8.61e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTM1—stomach cancer	4.04e-05	8.6e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MAPK8—stomach cancer	3.94e-05	8.4e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CA—stomach cancer	3.88e-05	8.27e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPP2R1A—stomach cancer	3.83e-05	8.15e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ERBB2—stomach cancer	3.81e-05	8.12e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ERCC2—stomach cancer	3.79e-05	8.08e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTP1—stomach cancer	3.75e-05	8e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HMOX1—stomach cancer	3.7e-05	7.89e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—VEGFA—stomach cancer	3.64e-05	7.76e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCL8—stomach cancer	3.62e-05	7.7e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—STAT3—stomach cancer	3.6e-05	7.68e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—HRAS—stomach cancer	3.59e-05	7.65e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MTHFR—stomach cancer	3.57e-05	7.6e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CDKN1B—stomach cancer	3.53e-05	7.52e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TYMS—stomach cancer	3.49e-05	7.43e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTM1—stomach cancer	3.45e-05	7.35e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MAPK3—stomach cancer	3.44e-05	7.34e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6—stomach cancer	3.44e-05	7.33e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCND1—stomach cancer	3.37e-05	7.18e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—JUN—stomach cancer	3.36e-05	7.16e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MYC—stomach cancer	3.35e-05	7.14e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CAV1—stomach cancer	3.29e-05	7.01e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOA1—stomach cancer	3.28e-05	6.99e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MAPK1—stomach cancer	3.28e-05	6.98e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EGFR—stomach cancer	3.28e-05	6.98e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MMP9—stomach cancer	3.27e-05	6.97e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	3.26e-05	6.94e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ERCC2—stomach cancer	3.24e-05	6.91e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MAPK8—stomach cancer	3.18e-05	6.78e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.14e-05	6.7e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—KRAS—stomach cancer	3.09e-05	6.59e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MTHFR—stomach cancer	3.05e-05	6.49e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—VEGFA—stomach cancer	2.94e-05	6.26e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—STAT3—stomach cancer	2.91e-05	6.19e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARG—stomach cancer	2.89e-05	6.16e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CA—stomach cancer	2.84e-05	6.06e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CAV1—stomach cancer	2.81e-05	5.99e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOA1—stomach cancer	2.8e-05	5.98e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MAPK3—stomach cancer	2.78e-05	5.92e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TP53—stomach cancer	2.75e-05	5.86e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MYC—stomach cancer	2.7e-05	5.76e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.69e-05	5.72e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MAPK1—stomach cancer	2.64e-05	5.63e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EGFR—stomach cancer	2.64e-05	5.63e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HRAS—stomach cancer	2.63e-05	5.6e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALB—stomach cancer	2.6e-05	5.54e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6—stomach cancer	2.52e-05	5.36e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—KRAS—stomach cancer	2.5e-05	5.32e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NOS3—stomach cancer	2.49e-05	5.3e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARG—stomach cancer	2.47e-05	5.27e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	2.29e-05	4.89e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTGS2—stomach cancer	2.28e-05	4.85e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALB—stomach cancer	2.22e-05	4.74e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TP53—stomach cancer	2.22e-05	4.73e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NOS3—stomach cancer	2.13e-05	4.53e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HRAS—stomach cancer	2.12e-05	4.52e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6—stomach cancer	2.03e-05	4.33e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTGS2—stomach cancer	1.94e-05	4.14e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.4e-05	2.98e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.2e-05	2.55e-05	CbGpPWpGaD
